Eric C. Salzman
Presently, Eric C. Salzman holds the position of Executive Chairman of Merisel, Inc. Mr. Salzman is also Chief Executive Officer of Safeguard Scientifics, Inc. and on the board of 5 other companies.
He previously was Chairman of SynCardia Systems LLC, Managing Member at SarniHaan Capital Partners LLC, MD-Global Trading Strategies Division at Lehman Brothers Holdings, Inc., MD-Global Trading Strategies Division at Lehman Brothers, Inc. and Mergers & Acquisitions Analyst at Credit Suisse First Boston Corp.
He received an undergraduate degree from the University of Michigan and an MBA from Harvard Business School.
|08/10/2020||11,146||Award at $0 per share.||0|
|08/07/2019||8,028||Derivative/Non-derivative trans. at $0 per share.||0|
|08/01/2019||7,424||Award at $0 per share.||0|
|10/21/2018||8,328||Derivative/Non-derivative trans. at $0 per share.||0|
|08/10/2018||13,409||Derivative/Non-derivative trans. at $22.4 per share.||300,361|
|09/20/2017||11,832||Derivative/Non-derivative trans. at $13.65 per share.||161,506|
|02/09/2017||9,700||Disposition at $15.64 per share.||151,708|
|02/09/2017||300||Disposition at $15.7 per share.||4,710|
|02/08/2017||15,000||Disposition at $15.26 per share.||228,900|
|07/22/2016||21,472||Derivative/Non-derivative trans. at $15.02 per share.||322,509|